Opportunity Information: Apply for RFA CA 14 503
Apply for RFA CA 14 503
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Limited Competition International Agency for Research on Cancer (IARC) Monographs Program (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.396 Cancer Biology Research 93.399 Cancer Control.
- This funding opportunity was created on Sep 4, 2014 and posted on Sep 4, 2014.
- Applicants must submit their applications by Dec 18, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $859,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $859,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following This is a limited competition FOA. Only the awardee institution for the International Agency for Research on Cancer (IARC) Monographs Program is eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Limited Competition International Agency for Research on Cancer (IARC) Monographs Program (U01) funding opportunity (RFA-CA-14-503) is a National Institutes of Health (NIH) cooperative agreement intended to support the renewal of the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. The Monographs program, supported largely by the National Cancer Institute (NCI), focuses on rigorous, critical evaluation of the published scientific literature to determine whether specific agents, mixtures, exposures, or circumstances pose carcinogenic hazards to humans. The end products, the IARC Monograph volumes, are widely used as authoritative references that help shape public health policy, guide cancer prevention strategies, and inform research priorities worldwide, with the overall goal of reducing the global cancer burden by clarifying carcinogenic risks.
This announcement is a limited competition renewal, meaning it is not open to the general research community. Eligibility is restricted to the institution that already holds the award supporting the IARC Monographs Program. In practical terms, the FOA is designed to continue an established, ongoing international evaluation effort rather than to create a new program at a different organization. The award mechanism is a U01 cooperative agreement, which typically indicates that NIH expects substantial involvement during the project period, such as programmatic coordination, collaboration on priorities, or other stewardship activities beyond what is common in a standard grant.
In terms of funding and scale, NIH anticipated making a single award under this announcement. The estimated total funding was $859,000, and the award ceiling was also $859,000, indicating the expected maximum amount available for the lone award. There is no cost-sharing or matching requirement. The opportunity was posted on September 4, 2014, with an application due date of December 18, 2014, and the announcement was later archived on January 18, 2015. The CFDA numbers associated with this opportunity reflect its alignment with NCI program areas, including Cancer Cause and Prevention Research (93.393), Cancer Biology Research (93.396), and Cancer Control (93.399), underscoring that the Monographs are relevant across prevention, mechanisms of carcinogenesis, and population-level cancer control.
As described, the central purpose of the supported work is the systematic assessment of scientific evidence on potential carcinogenic hazards. The Monographs program is known for bringing together expert working groups to review epidemiologic studies, animal bioassays, and mechanistic and other relevant data, then publishing consensus evaluations that are used internationally. Because these monographs are treated as critical reference materials, the program’s output has downstream effects on research agendas, risk communication, regulatory discussions, and interventions aimed at reducing exposure to carcinogenic hazards.
For applicants and stakeholders needing official details, NIH provided an additional information link to the full FOA text hosted in the NIH grants guide (http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-14-503.html). NIH also listed contacts through the NIH Office of Extramural Research (OER) webmaster addresses for technical issues accessing or linking to the announcement (FBOWebmaster@OD.NIH.GOV).
Frequently Asked Questions (FAQs)
What is the name and identifier of this funding opportunity?
This opportunity is titled "Limited Competition International Agency for Research on Cancer (IARC) Monographs Program (U01)" and is identified as RFA-CA-14-503.
Which agency is offering this opportunity?
The opportunity is offered through the National Institutes of Health (NIH).
What NIH institute primarily supports the IARC Monographs Program described here?
The program is supported largely by the National Cancer Institute (NCI).
What is the funding mechanism used for this award?
The award mechanism is a U01 cooperative agreement.
What does it mean that this is a U01 cooperative agreement?
Based on the description provided, a U01 cooperative agreement indicates NIH expects substantial involvement during the project period. This can include programmatic coordination, collaboration on priorities, or other stewardship activities beyond what is typical for a standard grant.
What is the main purpose of this grant?
The purpose is to support the renewal of the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans by enabling rigorous, critical evaluation of the published scientific literature to determine whether specific agents, mixtures, exposures, or circumstances pose carcinogenic hazards to humans.
What types of carcinogenic hazards are evaluated under the Monographs program?
The program evaluates potential carcinogenic hazards associated with specific agents, mixtures, exposures, or circumstances, using evidence from the published scientific literature.
What kinds of evidence are reviewed in the IARC Monographs process?
The description notes that expert working groups review epidemiologic studies, animal bioassays, mechanistic evidence, and other relevant data as part of the evaluation process.
What are the expected outputs or end products of the funded work?
The end products are IARC Monograph volumes that publish consensus evaluations of carcinogenic hazards.
How are the IARC Monographs used?
The monographs are described as widely used authoritative references that help shape public health policy, guide cancer prevention strategies, and inform research priorities worldwide.
What broader impact is the program intended to have?
The overall goal is to reduce the global cancer burden by clarifying carcinogenic risks, with downstream effects on research agendas, risk communication, regulatory discussions, and interventions aimed at reducing exposure to carcinogenic hazards.
Is this funding opportunity open to the general research community?
No. It is described as a limited competition renewal and is not open to the general research community.
Who is eligible to apply?
Eligibility is restricted to the institution that already holds the award supporting the IARC Monographs Program.
Why is this called a "limited competition renewal"?
The information provided explains that it is designed to continue an established, ongoing international evaluation effort rather than create a new program at a different organization.
How many awards did NIH anticipate making under this announcement?
NIH anticipated making a single award.
What was the estimated total funding amount for this opportunity?
The estimated total funding was $859,000.
What was the maximum award ceiling?
The award ceiling was $859,000, indicating the expected maximum amount available for the single award.
Is cost-sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
When was the opportunity posted?
The announcement was posted on September 4, 2014.
What was the application due date?
The application due date was December 18, 2014.
Is this funding opportunity still active?
No. The announcement was later archived on January 18, 2015.
Which CFDA program areas are associated with this opportunity?
The CFDA numbers listed are 93.393 (Cancer Cause and Prevention Research), 93.396 (Cancer Biology Research), and 93.399 (Cancer Control).
What do the listed CFDA areas suggest about the scope of the Monographs program?
The description indicates these CFDA alignments underscore that the Monographs are relevant across prevention, mechanisms of carcinogenesis, and population-level cancer control.
Where can someone find the official full FOA text?
NIH provided a link to the full FOA text in the NIH grants guide: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-14-503.html
Who should be contacted for technical issues accessing or linking to the announcement?
For technical issues, NIH listed the NIH Office of Extramural Research (OER) webmaster contact: FBOWebmaster@OD.NIH.GOV
What aspect of the work makes the Monographs "authoritative references" according to the description?
The program emphasizes rigorous, critical evaluation of published scientific literature and uses expert working groups to reach consensus evaluations that are published in the Monograph volumes.
Does the description indicate whether the program is international in nature?
Yes. It references the International Agency for Research on Cancer (IARC) and describes the work as an ongoing international evaluation effort with worldwide use and influence.
Browse more opportunities from the same category: Education Health
Next opportunity: National Park Service Conduct Ethnohistorical Study and Interviews Regarding Navajo Mormon contacts and Conflicts of the 1850s and 1870s
Previous opportunity: Planning Grants for Dental, Oral and Craniofacial Tissue Regeneration Consortium Resource Centers (R34)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 14 503
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 14 503) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing Interventions to Improve Medication Adherence (R21) Apply for PA 14 335 Funding Number: PA 14 335 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13) Apply for PAR 14 339 Funding Number: PAR 14 339 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Self Management for Health in Chronic Conditions (R01) Apply for PA 14 344 Funding Number: PA 14 344 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Self Management for Health in Chronic Conditions (R21) Apply for PA 14 343 Funding Number: PA 14 343 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Self Management for Health in Chronic Conditions (R15) Apply for PA 14 345 Funding Number: PA 14 345 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2016 (P50) Apply for PAR 14 353 Funding Number: PAR 14 353 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,300,000 |
| Epidemiology of Drug Abuse (R01) Apply for PA 15 003 Funding Number: PA 15 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epidemiology of Drug Abuse (R03) Apply for PA 15 002 Funding Number: PA 15 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Epidemiology of Drug Abuse (R21) Apply for PA 15 001 Funding Number: PA 15 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Office of American Schools and Hospitals Abroad (ASHA) Fiscal Year 2015 Program Apply for APS ASHA 15 000001 Funding Number: APS ASHA 15 000001 Agency: Agency for International Development Category: Education Health Funding Amount: $2,000,000 |
| Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21) Apply for PA 15 015 Funding Number: PA 15 015 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01) Apply for PA 15 017 Funding Number: PA 15 017 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15) Apply for PA 15 016 Funding Number: PA 15 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54) Apply for PAR 15 019 Funding Number: PAR 15 019 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,250,000 |
| National Cancer Institute Program Project Applications (P01) Apply for PAR 15 023 Funding Number: PAR 15 023 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanistic Studies of Pain and Alcohol Dependence (R01) Apply for PA 15 026 Funding Number: PA 15 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Promoting Research in Basic Neuroscience (R01) Apply for PAS 15 029 Funding Number: PAS 15 029 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Early Detection Research Network Biomarker Developmental Laboratories (U01) Apply for RFA CA 14 014 Funding Number: RFA CA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $400,000 |
| The Early Detection Research Network Clinical Validation Centers (U01) Apply for RFA CA 14 015 Funding Number: RFA CA 14 015 Agency: National Institutes of Health Category: Education Health Funding Amount: $600,000 |
| The Early Detection Research Network Biomarker Reference Laboratories (U24) Apply for RFA CA 14 016 Funding Number: RFA CA 14 016 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 14 503", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.